Yanting Zhu

2.3k total citations · 1 hit paper
93 papers, 1.8k citations indexed

About

Yanting Zhu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanting Zhu has authored 93 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 20 papers in Cancer Research and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanting Zhu's work include Cancer-related molecular mechanisms research (13 papers), Pulmonary Hypertension Research and Treatments (13 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Yanting Zhu is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), Pulmonary Hypertension Research and Treatments (13 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Yanting Zhu collaborates with scholars based in China, Hong Kong and United States. Yanting Zhu's co-authors include Manxiang Li, Jue Shi, Shaojun Li, Lihua Zhang, Daohua Shi, Cui Zhai, Peiguang Niu, Lu Liu, Xin Yan and Wenhua Shi and has published in prestigious journals such as Nature Communications, Hepatology and Cancer Research.

In The Last Decade

Yanting Zhu

85 papers receiving 1.7k citations

Hit Papers

Electrospun nanofiber as building blocks for high-perform... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanting Zhu China 24 882 370 322 243 217 93 1.8k
Hui Cheng China 26 888 1.0× 168 0.5× 204 0.6× 406 1.7× 328 1.5× 117 2.2k
Zehuan Liao Singapore 22 899 1.0× 134 0.4× 421 1.3× 232 1.0× 299 1.4× 40 2.1k
Jing Zhou China 28 847 1.0× 165 0.4× 244 0.8× 187 0.8× 238 1.1× 115 2.5k
Wenjing Chen China 19 470 0.5× 237 0.6× 219 0.7× 171 0.7× 339 1.6× 66 1.3k
Xiaomeng Zhang China 22 676 0.8× 240 0.6× 178 0.6× 99 0.4× 143 0.7× 105 1.7k
Guowei Chen China 23 670 0.8× 126 0.3× 329 1.0× 103 0.4× 231 1.1× 67 1.3k
Wenjing Wang China 27 577 0.7× 563 1.5× 225 0.7× 146 0.6× 475 2.2× 119 1.9k
Jinghua Zhao China 23 884 1.0× 142 0.4× 374 1.2× 530 2.2× 799 3.7× 54 2.5k

Countries citing papers authored by Yanting Zhu

Since Specialization
Citations

This map shows the geographic impact of Yanting Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanting Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanting Zhu more than expected).

Fields of papers citing papers by Yanting Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanting Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanting Zhu. The network helps show where Yanting Zhu may publish in the future.

Co-authorship network of co-authors of Yanting Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanting Zhu. A scholar is included among the top collaborators of Yanting Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanting Zhu. Yanting Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhu, Yanting, You‐Zhi Zhang, Li Liang, et al.. (2025). Total glucosides of paeony ameliorates lupus nephritis by suppressing ZBP1-mediated PANoptosis in podocytes. Phytomedicine. 145. 156996–156996. 1 indexed citations
3.
Zhu, Yanting, et al.. (2024). Advances and perspectives on emergent biomaterials for preventing tendon adhesion. Materials Today Communications. 40. 109430–109430. 2 indexed citations
4.
Liu, Hui, et al.. (2024). Electrospun nanofiber as building blocks for high-performance air filter: A review. Nano Today. 55. 102161–102161. 70 indexed citations breakdown →
5.
Yan, Xiaohui, et al.. (2024). USP19 Stabilizes TAK1 to Regulate High Glucose/Free Fatty Acid-induced Dysfunction in HK-2 Cells. Current Medical Science. 44(4). 707–717. 1 indexed citations
6.
Zeng, Hong, Xiaoyu Qu, Shengwei Tang, et al.. (2024). A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients. Journal of Inflammation Research. Volume 17. 10397–10419.
8.
Liu, Ying, et al.. (2023). Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma. BMC Complementary Medicine and Therapies. 23(1). 336–336. 2 indexed citations
9.
Bao, Nan, et al.. (2023). Diversity of Intestinal Flora in Elderly Patients with Type 2 Diabetes Mellitus with Early Nephropathy. Journal of Clinical and Nursing Research. 7(6). 167–171. 1 indexed citations
10.
Zhai, Cui, Nana Zhang, Jian Wang, et al.. (2022). Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation. Lung. 200(5). 619–631. 4 indexed citations
11.
Niu, Peiguang, et al.. (2021). Cardamonin inhibits the expression of P-glycoprotein and enhances the anti-proliferation of paclitaxel on SKOV3-Taxol cells. Journal of Natural Medicines. 76(1). 220–233. 8 indexed citations
12.
Huang, Bo, et al.. (2018). Cell type–dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance. Science Advances. 4(12). eaat5077–eaat5077. 32 indexed citations
13.
Shi, Daohua, et al.. (2018). Autophagy induced by cardamonin is associated with mTORC1 inhibition in SKOV3 cells. Pharmacological Reports. 70(5). 908–916. 25 indexed citations
14.
Shi, Daohua, et al.. (2018). Glycolysis inhibition via mTOR suppression is a key step in cardamonin-induced autophagy in SKOV3 cells. BMC Complementary and Alternative Medicine. 18(1). 317–317. 29 indexed citations
15.
Li, Ping, et al.. (2018). Requirement of Rab21 in LPS-induced TLR4 signaling and pro-inflammatory responses in macrophages and monocytes. Biochemical and Biophysical Research Communications. 508(1). 169–176. 21 indexed citations
16.
Shi, Wenhua, Cui Zhai, Wei Feng, et al.. (2018). Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation. Life Sciences. 210. 140–149. 42 indexed citations
17.
Liu, Lu, Yilin Pan, Yanting Zhu, et al.. (2017). Association between rhinovirus wheezing illness and the development of childhood asthma: a meta-analysis. BMJ Open. 7(4). e013034–e013034. 63 indexed citations
18.
Zhu, Yanting, Xin Yan, Cui Zhai, Lan Yang, & Manxiang Li. (2017). Association between risk of asthma and gene polymorphisms in CHI3L1 and CHIA: a systematic meta-analysis. BMC Pulmonary Medicine. 17(1). 193–193. 17 indexed citations
19.
Xie, Xinming, Shaojun Li, Yanting Zhu, et al.. (2017). Egr-1 mediates leptin-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells. Molecular Biology of the Cell. 29(3). 356–362. 9 indexed citations
20.
Liang, Jin, et al.. (2013). Resonance versus linear responses to alternating electric fields induce mechanistically distinct mammalian cell death. Bioelectrochemistry. 94. 61–68. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026